Amedisys, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0234361089
USD
100.99
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,348.32
2,236.38
2,223.20
2,214.11
2,071.52
1,955.63
1,662.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,348.32
2,236.38
2,223.20
2,214.11
2,071.52
1,955.63
1,662.58
Raw Material Cost
1,878.39
1,779.31
1,285.36
1,264.26
1,214.17
1,168.77
1,006.12
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
529.75
516.05
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.76
31.27
22.23
9.53
11.04
14.52
7.37
Selling and Distribution Expenses
29.03
26.08
754.06
703.58
658.20
592.53
501.31
Other Expenses
-56.05
-54.73
-2.22
-0.95
-1.10
-1.45
-0.74
Total Expenditure (Excl Depreciation)
1,907.42
1,805.39
2,039.42
1,967.84
1,872.37
1,761.29
1,507.43
Operating Profit (PBDIT) excl Other Income
440.90000000000003
431
183.79999999999998
246.29999999999998
199.1
194.3
155.1
Other Income
22.44
20.50
1.70
51.14
36.96
7.45
11.21
Operating Profit (PBDIT)
258.05
237.42
210.42
328.32
264.91
220.22
179.62
Interest
30.76
31.27
22.23
9.53
11.04
14.52
7.37
Exceptional Items
-115.03
-142.67
-3.01
-7.66
-14.25
-16.87
0.00
Gross Profit (PBDT)
469.93
457.08
937.84
949.86
857.35
786.87
656.45
Depreciation
26.04
23.85
24.93
30.90
28.80
18.43
13.26
Profit Before Tax
86.22
39.62
160.24
280.23
210.82
170.41
158.99
Tax
48.05
50.56
42.55
70.06
25.64
42.50
38.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
43.23
-9.75
118.61
209.07
183.61
126.83
119.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
43.23
-9.75
118.61
209.07
183.61
126.83
119.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.07
-1.19
-0.91
1.09
1.58
1.07
0.78
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
38.16
-10.94
117.70
210.17
185.18
127.91
120.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,134.54
1,066.51
1,051.57
931.35
809.22
640.45
481.58
Earnings per share (EPS)
1.31
-0.3
3.63
6.34
5.52
3.84
3.55
Diluted Earnings per share
1.31
-0.3
3.63
6.34
5.52
3.84
3.55
Operating Profit Margin (Excl OI)
8.92%
8.63%
8.27%
11.12%
9.61%
9.94%
9.33%
Gross Profit Margin
4.78%
2.84%
8.33%
14.05%
11.57%
9.66%
10.36%
PAT Margin
1.84%
-0.44%
5.34%
9.44%
8.86%
6.49%
7.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 5.00% vs 0.59% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 450.46% vs -109.26% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 8.62% vs 3.93% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -1.60% vs 40.99% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Amedisys, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,348.32
739.02
1,609.30
217.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,348.32
739.02
1,609.30
217.76%
Raw Material Cost
1,878.39
289.80
1,588.59
548.17%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
529.75
0.00
529.75
Power Cost
0
0
0.00
Manufacturing Expenses
30.76
2.58
28.18
1,092.25%
Selling and Distribution Expenses
29.03
545.06
-516.03
-94.67%
Other Expenses
-56.05
34.52
-90.57
-262.37%
Total Expenditure (Excl Depreciation)
1,907.42
1,182.61
724.81
61.29%
Operating Profit (PBDIT) excl Other Income
440.90
-443.59
884.49
199.39%
Other Income
22.44
55.49
-33.05
-59.56%
Operating Profit (PBDIT)
258.05
-345.72
603.77
174.64%
Interest
30.76
2.58
28.18
1,092.25%
Exceptional Items
-115.03
-44.40
-70.63
-159.08%
Gross Profit (PBDT)
469.93
449.22
20.71
4.61%
Depreciation
26.04
42.39
-16.35
-38.57%
Profit Before Tax
86.22
-435.09
521.31
119.82%
Tax
48.05
1.28
46.77
3,653.91%
Provisions and contingencies
0
0
0.00
Profit After Tax
43.23
-436.37
479.60
109.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
43.23
-436.37
479.60
109.91%
Share in Profit of Associates
0
0
0.00
Minority Interest
-5.07
0.00
-5.07
Other related items
0.00
0.00
0.00
Consolidated Net Profit
38.16
-436.37
474.53
108.74%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,134.54
-139.65
1,274.19
912.42%
Earnings per share (EPS)
1.31
-3.56
4.87
136.80%
Diluted Earnings per share
1.31
-3.56
4.87
136.80%
Operating Profit Margin (Excl OI)
8.92%
-60.02%
0.00
68.94%
Gross Profit Margin
4.78%
-53.14%
0.00
57.92%
PAT Margin
1.84%
-59.05%
0.00
60.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 234.83 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 5.00% vs 0.59% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 3.82 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 450.46% vs -109.26% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.62% vs 3.93% in Dec 2023

Annual - Interest
Interest 3.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.60% vs 40.99% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.92%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023